Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report

BACKGROUND: The majority of patients diagnosed with hepatocellular carcinoma (HCC) have advanced diseases and many are not eligible for curative therapies. CASE PRESENTATION: We report a rare case of HCC from a patient who had a complete response (CR) with the use of combination of Lenvatinib and Pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaonan, Li, Xingjie, He, Xuequn, Xu, Yingchun, Wang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839182/
https://www.ncbi.nlm.nih.gov/pubmed/31703571
http://dx.doi.org/10.1186/s12885-019-6287-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839182/
https://www.ncbi.nlm.nih.gov/pubmed/31703571
http://dx.doi.org/10.1186/s12885-019-6287-8

Ejemplares similares